摘要
背景:脑血管疾病和高血压在阿尔茨海默病(AD)的进展中起着至关重要的作用。然而,脑血管疾病和高血压是否通过一种独立的或相互作用的效应促进AD的进展尚不清楚。目的:探讨脑血管病与高血压相互作用对AD进展的影响。方法:对不同严重程度脑白质改变(WMCs)患者的AD病程进行回顾性纵向研究。进行年度综合心理测量学检查。WMCs采用年龄相关WMCs评定量表(ARWMC)。结果:本研究共收集散发性AD患者278例。患者平均年龄76.6}7.4岁,高血压166例。在高血压AD患者中,临床痴呆量表(CDR-SB)和CDR评分(CDR-SB:5.8比3.6,经调整P=0.0 4)均有明显的重度基线ARWMC评分(P=0.0 4);CDR:6.4 vs.4.4,调整后P=0.04)和额叶面积(CDR-SB:2.4 vs.1.2,调整P=0.01;CDR:2.4 vs.1.7,调整后P<0.01)。相反,在无高血压的AD患者中,ARWMC评分在有和没有恶化的患者之间没有显着性差异。结论:高血压患者与非高血压患者脑血管病变对AD进展的影响可能不同。高血压与WMCs相互作用而非独立影响AD的进展是可能的。
关键词: 血管紧张素转换酶插入/缺失多态性,阿尔茨海默病,脑血管病,脑白质改变,高血压,纵向研究。
Current Alzheimer Research
Title:Effect of the Interaction Between Hypertension and Cerebral White Matter Changes on the Progression of Alzheimer Disease
Volume: 15 Issue: 14
关键词: 血管紧张素转换酶插入/缺失多态性,阿尔茨海默病,脑血管病,脑白质改变,高血压,纵向研究。
摘要: Background: Cerebrovascular pathologies and hypertension could play a vital role in Alzheimer disease (AD) progression. However, whether cerebrovascular pathologies and hypertension accelerate the AD progression through an independent or interaction effect is unknown.
Objective: To investigate the effect of the interactions of cerebrovascular pathologies and hypertension on AD progression.
Method: A retrospective longitudinal study was conducted to compare AD courses in patients with different severities of cerebral White Matter Changes (WMCs) in relation to hypertension. Annual comprehensive psychometrics were performed. WMCs were rated using a rating scale for Age-related WMCs (ARWMC).
Results: In total, 278 patients with sporadic AD were enrolled in this study. The mean age of the patients was 76.6 ± 7.4 years, and 166 patients had hypertension. Among AD patients with hypertension, those with deterioration in clinical dementia rating-sum of box (CDR-SB) and CDR had significantly severe baseline ARWMC scales in total (CDR-SB: 5.8 vs. 3.6, adjusted P = 0.04; CDR: 6.4 vs. 4.4, adjusted P = 0.04) and frontal area (CDR-SB: 2.4 vs. 1.2, adjusted P = 0.01; CDR: 2.4 vs. 1.7, adjusted P < 0.01) compared with those with no deterioration in psychometrics after adjustment for confounders. By contrast, among AD patients without hypertension, no significant differences in ARWMC scales were observed between patients with and without deterioration.
Conclusion: The effect of cerebrovascular pathologies on AD progression between those with and without hypertension might differ. An interaction but not independent effect of hypertension and WMCs on the progression of AD is possible.
Export Options
About this article
Cite this article as:
Effect of the Interaction Between Hypertension and Cerebral White Matter Changes on the Progression of Alzheimer Disease, Current Alzheimer Research 2018; 15 (14) . https://dx.doi.org/10.2174/1567205015666181002141013
DOI https://dx.doi.org/10.2174/1567205015666181002141013 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
MicroRNA: Implications for Alzheimer Disease and other Human CNS Disorders
Current Genomics Long-Term Exposure to Ambient Hydrocarbons Increases Dementia Risk in People Aged 50 Years and above in Taiwan
Current Alzheimer Research Alcohol and the Cardiovascular System: A Double-Edged Sword
Current Pharmaceutical Design The Impetus of COVID -19 in Multiple Organ Affliction Apart from Respiratory Infection: Pathogenesis, Diagnostic Measures and Current Treatment Strategy
Infectious Disorders - Drug Targets Memory Deficits Correlating with Acetylcholinesterase Splice Shift and Amyloid Burden in Doubly Transgenic Mice
Current Alzheimer Research Bedtime Hypertension Chronotherapy: Concepts and Patient Outcomes
Current Pharmaceutical Design Alzheimer’s Disease: Physical Activities as an Effective Intervention Tool - A Mini-Review
Current Alzheimer Research Clinical Significance of the Cardio-Ankle Vascular Index (CAVI) in Hypertension
Current Hypertension Reviews Therapeutic Application of Intrabodies Against Age-Related Neurodegenerative Disorders
Current Pharmaceutical Design Neuropsychiatric Disturbances in Alzheimer’s Disease: What Have We Learned from Neuropathological Studies?
Current Alzheimer Research Ubiquitin-Proteasome Pathway Components as Therapeutic Targets for CNS Maladies
Current Pharmaceutical Design Sensory-Dependent Knowledge in Young and Elderly Adults: Argument from the Cross-Modal Priming Effect
Current Aging Science Partial Dopamine Agonists and Dopaminergic Stabilizers, in the Treatment of Psychosis
Current Drug Targets - CNS & Neurological Disorders The Importance of NAD in Multiple Sclerosis
Current Pharmaceutical Design Identification of High-affinity Small Molecules Targeting Gamma Secretase for the Treatment of Alzheimer’s Disease
Current Topics in Medicinal Chemistry Allosteric Enhancers for A1 Adenosine Receptor
Mini-Reviews in Medicinal Chemistry Endogenous Retroelements in Cellular Senescence and Related Pathogenic Processes: Promising Drug Targets in Age-Related Diseases
Current Drug Targets Synthesis, Physico-Chemical Properties and DFT Calculations of New 2-(4- Arylpiperazine-1-yl)-1-(3-ethylbenzofuran-2-yl)ethanols As Potential Antihypertensive Agents
Current Organic Chemistry Endoplasmic Reticulum Dysfunction in Brain Pathology: Critical Role of Protein Synthesis
Current Neurovascular Research Hyperhomocysteinaemia: A Critical Review of Old and New Aspects
Current Drug Metabolism